$3 Radio play-
Audacy rises 10.7% 10:00 AUD
Biolase sees Q3 revenue 'significantly above' year-ago quarter 09:16 BIOL Along with its earnings report last night, Biolase stated: "The company continues to experience high demand for its dental lasers and is currently forecasting revenue for the third quarter ending September 30, 2021, to be significantly above the year-ago third quarter despite the pent up demand the company experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter. Even though the third quarter of the year is seasonally our second weakest revenue quarter, we expect the third quarter of 2021 to approach revenues we achieved in the second quarter of 2021." In pre-market trading, Biolase shares are up 31c, or 49%, to 94c.
Now
BIOLASE, Inc. (BIOL)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.8364+0.2048 (+32.43%)
As of 10:08AM EDT. Market open.
Audacy rises 10.7% 10:00 AUD
Biolase sees Q3 revenue 'significantly above' year-ago quarter 09:16 BIOL Along with its earnings report last night, Biolase stated: "The company continues to experience high demand for its dental lasers and is currently forecasting revenue for the third quarter ending September 30, 2021, to be significantly above the year-ago third quarter despite the pent up demand the company experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter. Even though the third quarter of the year is seasonally our second weakest revenue quarter, we expect the third quarter of 2021 to approach revenues we achieved in the second quarter of 2021." In pre-market trading, Biolase shares are up 31c, or 49%, to 94c.
Now
BIOLASE, Inc. (BIOL)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.8364+0.2048 (+32.43%)
As of 10:08AM EDT. Market open.